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ABSTRACT: Real-time, isothermal, digital nucleic acid ampliﬁca-
tion is emerging as an attractive approach for a multitude of
applications including diagnostics, mechanistic studies, and assay
optimization. Unfortunately, there is no commercially available and
aﬀordable real-time, digital instrument validated for isothermal
ampliﬁcation; thus, most researchers have not been able to apply
digital, real-time approaches to isothermal ampliﬁcation. Here, we
generate an approach to real-time digital loop-mediated isothermal
ampliﬁcation (LAMP) using commercially available microﬂuidic
chips and reagents and open-source components. We demonstrate
this approach by testing variables that inﬂuence LAMP reaction
speed and the probability of detection. By analyzing the interplay of
ampliﬁcation eﬃciency, background, and speed of ampliﬁcation,
this real-time digital method enabled us to test enzymatic performance over a range of temperatures, generating high-precision
kinetic and end-point measurements. We were able to identify the unique optimal temperature for two polymerase enzymes
while accounting for ampliﬁcation eﬃciency, nonspeciﬁc background, and time to threshold. We validated this digital LAMP
assay and pipeline by performing a phenotypic antibiotic susceptibility test on 17 archived clinical urine samples from patients
diagnosed with urinary tract infections. We provide all the necessary workﬂows to perform digital LAMP using standard
laboratory equipment and commercially available materials. This real-time digital approach will be useful to others in the future
to understand the fundamentals of isothermal chemistries, including which components determine ampliﬁcation fate, reaction
speed, and enzymatic performance. Researchers can also adapt this pipeline, which uses only standard equipment and
commercial components, to quickly study and optimize assays using precise, real-time digital quantiﬁcation, accelerating
development of critically needed diagnostics.
I n this paper, we describe a methodology to usecommercially available chips, reagents, and microscopes to
perform real-time digital LAMP. We use this methodology to
perform a mechanistic study of digital isothermal ampliﬁcation
and apply the lessons learned to perform a phenotypic
antibiotic susceptibility test (AST).
Microﬂuidics-based diagnostics for infectious diseases are
advancing as a result of using nucleic acid testing, making them
amenable to the point of care (POC) and limited-resource
settings where they will have clinical impact. Isothermal
ampliﬁcation methods in particular show promise for
simplifying nucleic acid-based POC diagnostics by circum-
venting the stringent thermal cycling requirements of PCR.1
One isothermal method that is being actively pursued in
bioanalytical chemistry and the ﬁeld of diagnostics is loop-
mediated isothermal ampliﬁcation (LAMP).2−6
LAMP and other isothermal technologies are fast and
sensitive, but when performed in a bulk format in microliter
volumes (e.g., in a tube), they provide only semiquantitative
(log-scale) resolution or presence/absence measurements.7−15
As a result, when optimizing an assay, it is diﬃcult to quantify
how small changes in assay conditions (e.g., in primers,
reagents, or temperature) impact the reaction’s speed and
analytical sensitivity. To reliably understand these eﬀects with
high precision would require hundreds of bulk experiments per
condition.16 For the ﬁeld to be able to take full advantage of
the capabilities of LAMP, researchers need to be able to
optimize reaction conditions by understanding and testing the
variables that may inﬂuence reaction speed and probability of
detection. Furthermore, the semiquantitative measurements
yielded by bulk isothermal methods are insuﬃcient for analyses
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requiring precise quantiﬁcation, such as phenotypic antibiotic
susceptibility testing.17,18
These problems can be solved using “digital” approaches,
which partition single target molecules in large numbers of
compartments and give a binary (presence/absence) readout
for each compartment. These “digital” approaches thus allow
determination of the eﬃciency of the ampliﬁcation reaction19
and provide absolute quantiﬁcation with high resolution.
Digital isothermal measurements have been used to quantify
viral load for HCV,16,20,21 HIV,19,20 and inﬂuenza,22 perform
bacterial enumeration,23−25 optimize primers,16 and test for
phenotypic antibiotic susceptibility18 using LAMP18−28 and
RPA.29
Real-time digital formats are especially valuable for
examining the variables that most aﬀect nonspeciﬁc ampliﬁca-
tion and the speed of ampliﬁcation. Many excellent approaches
for end-point19,20,22−28 and real-time16,18,21 digital LAMP
(dLAMP) have been published. Despite the value that real-
time dLAMP can bring to diagnostics, this method is diﬃcult
to implement, especially for those without a background in
microelectromechanical systems or microﬂuidics, because
there is no commercial system for real-time, digital isothermal
ampliﬁcation. To achieve statistical signiﬁcance, a meaningful
study might require dozens of experiments; such studies are
diﬃcult to perform without a commercial source of chips.
Consequently, the few LAMP mechanistic studies that have
been performed were not done with high precision. Further,
those who would most beneﬁt from optimized digital
isothermal reactions (e.g., those working on POC diagnostics)
cannot eﬃciently improve them.
Here, we demonstrate how to generate high-precision
kinetic and end-point measurements using a real-time
dLAMP assay that is performed completely with commercially
available and open-source components (Figure 1). We use this
real-time information to investigate dLAMP reactions mech-
anistically, including the interplay of eﬃciency, speed, and
background ampliﬁcation as a function of reaction temperature
and time on two enzymes. To illustrate one application of
using real-time dLAMP to improve a clinically relevant assay,
we optimized the assay conditions for a phenotypic AST using
the real-time dLAMP pipeline and used the optimized protocol
to compare our AST of 17 clinical urine samples to the gold-
standard method.
■ EXPERIMENTAL SECTION
Microﬂuidic chips used in this paper were sourced from
Applied Biosystems, Foster City, CA, USA, ref A26316,
“QuantStudio 3D Digital PCR 20k Chip Kit V2.”
LAMP Reagents. Our ampliﬁcation target was the
Escherichia coli 23S ribosomal gene, which we used previously
as a target to perform rapid AST on clinical samples.18 Primers
were purchased through Integrated DNA Technologies (San
Diego, CA, USA) and were described previously.18 Final
primer concentrations were identical for all experiments: 1.6
μM FIP/BIP, 0.2 μM FOP/BOP, and 0.4 μM LoopF/LoopB.
LAMP experiments using Bst 3.0 (Figure 2; Figure
3b,d,e,f,h−j; Figure 4) contained the following ﬁnal concen-
trations, optimized previously:18 1× Isothermal Ampliﬁcation
Buﬀer II (New England BioLabs (NEB), Ipswich, MA, USA;
ref B0374S, containing 20 mM Tris-HCl 10 mM (NH4)2SO4,
150 mM KCl, 2 mM MgSO4, 0.1% Tween 20 pH 8.8 at 25
°C), 4 mM additional MgSO4 (beyond 2 mM from buﬀer), 1.4
mM Deoxynucleotide Solution Mix. Primers: 1.6 μM FIP/BIP,
0.2 μM FOP/BOP, and 0.4 μM LoopF/LoopB, 1 mg/mL BSA
(New England BioLabs, ref B90005), 320 U/mL Bst 3.0,
Ambion RNase cocktail (ThermoFisher, Waltham, MA, USA;
ref AM2286, 5 U/mL RNase A, 400 U/mL TNase T1), 2 μM
SYTO 9 (ThermoFisher, ref S34854), and approximately 660
copies/μL template in Ambion nuclease-free water (Thermo-
Fisher, ref AM9932).
LAMP experiments using Bst 2.0 (Figure 3a,c,e,g) contained
the following ﬁnal concentrations, optimized as shown in
Supporting Information, Figure S3: 1× Isothermal Ampliﬁca-
tion Buﬀer (New England BioLabs; ref B0537S, containing 20
mM Tris-HCl 10 mM (NH4)2SO4, 50 mM KCl, 2 mM
MgSO4, 0.1% Tween 20 pH 8.8 at 25 °C), additional 6 mM
MgSO4 (New England BioLabs; ref B1003S), 1.4 mM
Deoxynucleotide Solution Mix (New England BioLabs; ref
N0447S). Primers: 1.6 μM FIP/BIP, 0.2 μM FOP/BOP, and
0.4 μM LoopF/LoopB, 1 mg/mL BSA (New England BioLabs;
ref B90005), 320 U/mL Bst 2.0 (New England BioLabs; ref
M0537S), Ambion RNase cocktail (ThermoFisher, ref
AM2286, 5 U/mL RNase A, 400 U/mL TNase T1), 2 μM
SYTO 9 (ThermoFisher, ref S34854), and approximately 660
copies/μL template in Ambion nuclease-free water (Thermo-
Fisher; ref AM9932).
Template E. coli DNA was extracted from exponential-phase
cultures grown in BBL Brain−Heart Infusion media (BD,
Franklin Lakes, NJ, USA; ref 221813) using QuickExtract
DNA Extraction Solution (Lucigen, Middleton, WI, USA; ref
QE09050) as described previously.18 Serial 10-fold dilutions
were prepared in Tris-EDTA buﬀer (5 mM Tris-HCl, 0.5 mM
EDTA, pH 8.0) containing 2 U/mL RNase A and 80 U/mL
RNase T1 (ThermoFisher; ref AM2286). DNA dilutions were
quantiﬁed as described previously18 using the QX200 droplet
digital PCR (ddPCR) system (Bio-Rad Laboratories, Hercules,
CA, USA).
Phenotypic Antibiotic Susceptibility Testing (AST) on
Clinical Samples. For the phenotypic AST, we adopted a
workﬂow described previously17,18 and used archived nucleic
acid extractions from a previous study.18 Brieﬂy, clinical urine
samples from patients with urinary tract infections (UTI) were
split and diluted into equal volumes of media with or without
Figure 1. A schematic of the pipeline for performing multiplexed, real-
time, digital loop-mediated isothermal ampliﬁcation (LAMP) using
only commercially available and/or open source components.
Microﬂuidic chips and reagents (e.g., primers, enzymes, buﬀer
composition) can be purchased commercially. Multiple instrument
conﬁgurations can be used to capture results, e.g., a customized real-
time instrument (instructions for building publicly available30) or any
commercial microscope. Data analysis is automated using a MATLAB
script (Supporting Information, S-I).
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the presence of an antibiotic. Samples were incubated for 15
min at 37 °C, a nucleic acid extraction was performed, and
these samples were archived at −80 °C until use. LAMP was
performed on the archived samples to quantify the number of
copies of the E. coli 23S ribosomal gene.
We tested our optimized assay on 17 archived clinical UTI
samples containing ≥5 × 104 CFU/mL E. coli that had been
categorized previously using the gold-standard broth micro-
dilution AST (ﬁve ciproﬂoxacin-susceptible, ﬁve ciproﬂoxacin-
resistant, four nitrofurantoin-susceptible, and three nitro-
furantoin-resistant).
We assessed samples as phenotypically “resistant” or
“susceptible” by calculating the ratio of the concentration of
23S in the control and antibiotic-treated sample, which we call
the control:treated (C:T) ratio. The C:T ratio was calculated
10 min after beginning to heat the LAMP reaction. A threshold
of 1.1 was established previously,17,18 so samples with C:T
ratios >1.1 indicated that there was DNA replication in the
untreated (control) group but not in the antibiotic-treated
samples; these samples were identiﬁed as susceptible to the
antibiotic. Samples with C:T ratios of <1.1 indicated that DNA
replication occurred in both the control and antibiotic-treated
samples; these samples were identiﬁed as resistant to the
antibiotic.
■ RESULTS AND DISCUSSION
Workﬂow Summary of Real-Time Digital LAMP. To
evaluate a pipeline for real-time dLAMP experiments, we chose
commercially sourced microﬂuidic chips sold for end-point
digital PCR applications. The chips consist of an array of
20000 uniform partitions (Figure 1), each 60 μm in diameter
and an estimated 0.75 nL internal volume, which is similar to
the volumes typically used in dLAMP.16,18,20−23,25,26,28 These
chips are loaded by pipetting the sample mixture (in our case
containing the LAMP reagents: buﬀer components, enzymes,
template, and primers) into the plastic “blade” provided with
the chips and dragging the blade at a 70−80° angle to the chip
to load the sample mixture by capillarity. This is followed by
drying and evaporation of the surface layer for 20 s at 40 °C
and application of the immersion ﬂuid. Manual loading
requires some skill, although a machine can be purchased to
perform the task; typically, we were able to load ∼18000 out of
the 20000 partitions. We performed our evaluation using two
diﬀerent enzyme mixtures, Bst 2.0 and Bst 3.0. Our
ampliﬁcation target (Figure 1) was the E. coli 23S ribosomal
gene that we previously used as a target to perform rapid AST
on clinical samples.18
The instrumentation requirements for real-time isothermal
capabilities include a heater that can hold a stable temperature
and optical components with high spatial resolution that are
capable of imaging the ﬂuorescence intensity of the 20000
individual partitions of the chip over time (Figure 2a). Here,
we investigated two approaches: using a standard laboratory
microscope (Leicia DMI-6000B), and using the RTAI,30 which
is composed of a thermocycler, optical components, a camera,
and a light source.
We generated a custom MATLAB script to analyze the
digital real-time data (details in Supporting Information, S-I).
The software follows the change in ﬂuorescence in individual
partitions over time. From these data, we extracted each
partition’s time to a ﬂuorescence intensity threshold and
calculated the bulk template concentration. In our demon-
stration, we loaded the acquired images into FIJI31 as a time-
stack series and manually separated the images of the
individual chips to be analyzed separately. To process each
chip’s image stack, we used the custom MATLAB script that
tracks the mean intensity of each partition over the course of
Figure 2. Experimental demonstration of the real-time digital LAMP
(dLAMP) approach using the commercially available enzyme Bst 3.0.
Experiments were run at 70 °C and imaged using a commercial
microscope. (a) A time course of ﬂuorescence images from a subset of
350 partitions out of 20000 partitions undergoing dLAMP reactions
(intensity range 920−1705 RFU). (b) Fluorescence intensity for a
subset of partitions over time. Blue traces indicate partitions
containing template; red traces indicate ﬂuorescence in the absence
of template (i.e., nonspeciﬁc ampliﬁcation). Partitions turn “on” at the
time point when the curve passes the threshold at 250 RFU. Vertical
traces correspond to time points illustrated in (a) and generate end-
point measurements. (c) An “end-point” measurement taken on a
subset of partitions at 25 min. Bin width is 100 RFU. Fluorescence
threshold is 250 RFU. (d) A histogram of the maximum observed
change in ﬂuorescence of individual partitions using the full chip. Rate
threshold is 45 RFU/30 s. (e) Change in observed bulk concentration
over time from the full chip using ﬂuorescence intensity as threshold
(solid lines) and rate (dashed lines). (f) Time at which individual
partitions in (b) cross the ﬂuorescence intensity threshold. (g)
Maximum rate per partition plotted by time to ﬂuorescence intensity
threshold.
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each experiment. This script could be run with only minor
modiﬁcations with images obtained from diﬀerent instruments.
To calculate the bulk template concentration over time, we
(1) identiﬁed the partitions that did or did not contain
reaction solution, (2) tracked the partitions that met a
minimum ﬂuorescence intensity, and (3) used the previous
information to calculate the concentration of template in the
bulk solution.
A summary of the script is as follows: (i) load the images
into memory, (ii) count the total number of partitions before
heating, (iii) identify positive partitions after the conclusion of
the experiment, (iv) track the intensity of positive partitions for
each image frame, (v) apply Gaussian smoothing and baseline
subtraction, (vi) save the data, and (vii) repeat for each image
stack. The output of the script contains: the raw traces of
individual partitions over time, baseline corrected traces of
individual partitions over time (Figure 2b), the number of
partitions exceeding the manually deﬁned minimum ﬂuo-
rescence intensity threshold with time (Figure 2f), and the
maximum relative rate in RFU per 30 s for individual partitions
(Figure 2d). These data provide all the necessary information
to conduct the analyses detailed in Figure 2.
Digital, Real-Time Experiments to Quantify LAMP
Performance. We next sought to experimentally evaluate this
pipeline (Figure 1). First, we established whether the
ﬂuorescence from LAMP reactions could be reliably measured
from individual partitions over time (Figure 2a). We used
LAMP reagents for Bst 3.0, commercial chips, a resistive heater
held at 70 °C, and a commercial microscope. Although the
microscope is capable of collecting all 20000 partitions on one
chip in a single image, for simplicity, in Figure 2a, we cropped
the image to include only 350 of the 20000 partitions. Before
turning on the heater (t = 0), we measured the
autoﬂuorescence from SYTO 9 to quantify the total number
of partitions loaded with reaction solution. (To calculate
template concentration using the Poisson distribution,32,33 we
must know the total number of partitions containing the
reaction mixture.) Autoﬂuorescence from SYTO 9 decreases as
the chip is heated and is completely eliminated within 3 min.
The heater used on the microscope reaches reaction
temperature within 120 s. In less than 10 min, an increase in
ﬂuorescence was observed within some of the individual
partitions, indicating ampliﬁcation of individual template
molecules inside those partitions. Because of the stochastic
nature of ampliﬁcation initiation, some of the partitions
ﬂuoresced later.
In the negative-control (no template) partitions, ﬂuores-
cence was not observed for the ﬁrst 45 min. However, we
began to observe nonspeciﬁc ampliﬁcation after ∼60 min. In
these experiments, the negative control contains only 0.05×
Tris-EDTA buﬀer in place of template and represents a best-
case scenario. We attribute ampliﬁcation in the absence of
template to primer dimers and other nonspeciﬁc LAMP
products.
Second, we asked if the signal from nonspeciﬁc ampliﬁcation
was suﬃciently delayed to diﬀerentiate it from the signal
arising from speciﬁc ampliﬁcation in the presence of template.
To answer this question, we generated real-time ﬂuorescence
curves by plotting the change in ﬂuorescence of individual
partitions as a function of time (Figure 2b). We observed
speciﬁc ampliﬁcation (blue curves) beginning to initiate at ∼7
min and nonspeciﬁc ampliﬁcation beginning to initiate at ∼50
min (red curves) and concluded that we could discriminate
speciﬁc and nonspeciﬁc ampliﬁcation by time.
Third, we asked whether enzymatic heterogeneity16,21,34 of
speciﬁc ampliﬁcation can be quantiﬁed to diﬀerentiate speciﬁc
from nonspeciﬁc ampliﬁcation. We plotted the maximum
change of ﬂuorescence achieved by each partition of the full
chip per 30 s interval (Figure 2d). For the negative-control
sample (red bars), we observed nonspeciﬁc ampliﬁcation
following a bimodal distribution of rates, with a ﬁrst peak with
little to no rate of ﬂuorescence increase and a second peak at
∼25 RFU per 30 s. For the sample containing template (blue
bars), rates for speciﬁc ampliﬁcation were heterogeneous and
centered around a rate of 70 RFU/30 s. We note that in PCR,
which is gated by temperature cycling, there is no equivalent
concept of “rate” as long as replication of DNA occurs faster
that the duration of each elongation step. We found in our
dLAMP experiments that the rate of speciﬁc ampliﬁcation was
greater than nonspeciﬁc ampliﬁcation. Hence, tracking
Figure 3. Evaluation of reaction conditions (enzymes and temper-
ature) using real-time digital LAMP. (a,b) Ampliﬁcation eﬃciency
(percent template copies detected out of copies loaded) of Bst 2.0 (a)
and Bst 3.0 (b) as a function of temperature. Green boxes indicate the
optimal temperature range for the greatest probability of template
detection. (c,d) Nonspeciﬁc ampliﬁcation in template-free buﬀer
samples using Bst 2.0 (c) and Bst 3.0 (d) for conditions matching (a)
and (b). (e,f) Distribution of time to ﬂuorescence threshold using Bst
2.0 (e) and Bst 3.0 (f). (g) The fractional cumulative distribution
function (CDF) compares the enzymes at their optimal temperatures
(68 °C). (h) Fractional CDF plots of Bst 3.0 rate at three
temperatures. Error bars are SD. For all data sets, N = 3 chips
(technical replicates). CDF plots are the sum of three technical
replicates.
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ampliﬁcation in real-time made it possible to distinguish true
positives from false positives (nonspeciﬁc ampliﬁcation).
Fourth, we asked if the distribution in time to ﬂuorescence
threshold is suﬃciently narrow to discriminate speciﬁc and
nonspeciﬁc ampliﬁcation. By plotting the number of “on”
partitions (i.e., partitions that crossed the ﬂuorescence
intensity threshold deﬁned in Figure 2b) against time, we
generated a distribution curve (Figure 2f) that illustrates the
number of partitions that turn on per time point. This is
related to the derivative of the change in concentration over
time. This plot contains the time to threshold of all partitions
within the entire chip, rather than a subset, to minimize
sampling bias. In the sample containing template (blue curve),
most partitions reached the threshold in 7−20 min, whereas
the negative-control sample (red curve) had little nonspeciﬁc
ampliﬁcation until approximately 60 min. Graphing time to
threshold (Figure 2f) illustrates the overall reaction’s speed
(deﬁned as the location of the peak or mode time to
threshold) and eﬃciency (proportional to the area under the
curve and illustrated in Figure 2e as the calculated
concentration). In our experiment, the peak of the sample
containing template was narrow and well separated from the
nonspeciﬁc ampliﬁcation of the negative control (Figure 2f),
indicating suﬃciently low heterogeneity in ampliﬁcation rate
and time to initiation of the reaction.
Fifth, we asked how the calculated bulk concentration
changes over time. To answer this question, we generated end-
point-style measurements for each 30 s time point and
calculated how the concentration changed over time. To
demonstrate how to generate a single end-point-style measure-
ment, we selected one time point (25 min) and plotted RFU as
a factor of the number of partitions (Figure 2c). Partitions
were classiﬁed as either “on” (>250 RFU threshold) or “oﬀ”
(<250 RFU threshold). Partitions that are deﬁned as having
turned “on” contain a template molecule that ampliﬁed,
whereas partitions that are ”oﬀ” either lack a template molecule
or have not yet begun ampliﬁcation. The sum of the partitions
passing the threshold out of the total number of partitions with
solution was used to determine a precise bulk concentration of
template in the sample using the Poisson equation, as has been
documented elsewhere.32,33 We plotted the calculated
concentration as it changed over time in Figure 2e (solid
lines).
When the aim is to determine a precise concentration, we
need to determine the best time at which to stop the assay.
Deciding the best time to end the assay is complicated because
each reaction initiates stochastically,16,21 causing the calculated
concentration to asymptotically approach the true concen-
tration (Figure 2e). It would be ideal for the calculated
concentration to rapidly rise to the true bulk concentration and
plateau near the true concentration; however, the reaction
should be stopped before the rise in nonspeciﬁc ampliﬁcation
(observed in our example starting at 60 min; red curves, Figure
2e,f). We tested whether there is heterogeneity in ampliﬁcation
rate (i.e., whether partitions with slow ampliﬁcation rates take
longer to reach the ﬂuorescence intensity threshold than
partitions with fast ampliﬁcation rates) and found that
initiation time was stochastic, but the reaction rates for true
and false positives were consistent (Figure 2g). Hence, two
molecules could have the same TTP yet initiate at diﬀerent
moments, resulting in variable ampliﬁcation rates.
Combining information about the concentration of template
(Figure 2e) and the time it takes for partitions to turn “on”
(Figure 2f) can be used to inform the choice of an optimal
assay length for end-point measurements for situations where
real-time quantiﬁcation is not feasible. For example, in Figure
2, the optimal assay length for an end-point readout would be
∼45 min. This approach allows one to balance stochastic
initiation of ampliﬁcation, overcome enzymatic heterogeneity,
and reduce the incidence of false positives caused by
nonspeciﬁc ampliﬁcation.
However, in cases where real-time measurements are
desirable, thresholding by rate may be used to separate speciﬁc
and nonspeciﬁc ampliﬁcation. For example, to correct for the
observed increase in nonspeciﬁc ampliﬁcation (after 45 min),
we implemented a threshold (Figure 2d) on the maximum rate
per partition, thus eliminating some of the nonspeciﬁc
ampliﬁcation in both the presence and absence of template
(compare solid and dashed lines in Figure 2e). For example,
the measured value at 60 min is 280 copies per μL (solid line),
and the corrected value is 258 copies per μL (dashed line). In
the no-template control, at 60 min, the measured value is 16
copies per μL (solid line), whereas the corrected value is 3
copies per μL (dashed line). The correction is more
pronounced at 80 min where nonspeciﬁc ampliﬁcation is
greater. At 80 min, the measured value in the presence of
template is 325 copies per μL and the corrected value 266
copies per μL, indicating that almost 20% of the signal could
arise from nonspeciﬁc ampliﬁcation. In the absence of
template, the uncorrected value at 80 min is 187 copies per
μL, however if the rate is accounted for, then the value can be
corrected to 16 copies per μL, thus eliminating the majority of
the false positives.
Finally, we note that although we calculated template
concentration, the value is precise but could be inaccurate if
not all target molecules loaded into the chip undergo
ampliﬁcation (in other words, if eﬃciency of ampliﬁcation is
not 100%). Thus, we next sought to measure the absolute
likelihood of detecting a molecule as a function of reaction
condition.
Evaluation of the Eﬀect of Temperature on dLAMP
with Two Diﬀerent Enzymes to Analyze the Interplay of
Ampliﬁcation Eﬃciency, Background, and Speed of
Ampliﬁcation. After establishing a protocol for generating
real-time, digital measurements, we evaluated the absolute
ampliﬁcation eﬃciency of LAMP as a function of temperature
for two diﬀerent enzymes. We selected two commercial
polymerases that worked well for us previously. Both enzymes
are in silico homologues on the Bacillus stearothermophilus
DNA polymerase I and large fragment. NEB describes Bst 3.0
as an improvement of Bst 2.0 by adding reverse transcriptase
activity, increased ampliﬁcation speed, and increased thermo-
stability. We sought to understand the diﬀerences in
performance between these two enzymes at the single-template
level. For this experiment, we used the previously described
RTAI.30 The ﬁeld of view for this instrument is larger than a
microscope, allowing up to six samples to be observed
concurrently. Hence, both the positive and negative controls
could be collected in triplicate simultaneously. We expect some
diﬀerences in measurements made on diﬀerent instruments as
a result of diﬀering camera sensitivities and diﬀerences in the
heating mechanism. Indeed, when we ran a single-concen-
tration ampliﬁcation reaction under identical conditions and
compared measurements from the microscope and the RTAI,
we found that there was signiﬁcant diﬀerence (P = 0.03) in
ampliﬁcation eﬃciency between the two instruments (Support-
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ing Information, Figure S2), with the RTAI generating higher
ampliﬁcation eﬃciency. Hence, we performed all enzyme−
performance comparisons on a single instrument.
Ampliﬁcation Eﬃciency. First, we sought to establish the
ampliﬁcation eﬃciency of dLAMP, i.e., the fraction of template
copies loaded that are detected (Figure 3a,b). We calculated
the bulk concentration of template molecules from the digital
measurement and plotted the observed template concentration
as a fraction of template molecules loaded. To calculate the
ampliﬁcation eﬃciency, we determined template concentration
using ddPCR and assumed all template molecules were
ampliﬁed. Using the real-time component of our measure-
ments, we plotted the percent of copies detected over time
compared with ddPCR.
We next asked how temperature impacts ampliﬁcation
eﬃciency. In general, we observed greater ampliﬁcation
eﬃciency at longer ampliﬁcation times, which aligned with
our previous observation (Figure 2d,e). Second, when
observing at a ﬁxed time, increasing temperature increased
ampliﬁcation eﬃciency to an optimum (green box in Figure
3a,b) before activity decreased.
Several observations can be made by comparing the results
from Bst 2.0 and Bst 3.0 (Figure 3a,b). Although Bst 2.0 and
Bst 3.0 have an identical reported optimal incubation
temperature in bulk (65 °C), we observed they had diﬀerent
optimal temperature ranges for ampliﬁcation eﬃciency (Bst 2.0
at 66−68 °C; Bst 3.0 at 68−70 °C). We detected lower
ampliﬁcation eﬃciency at higher temperatures with Bst 2.0
compared with Bst 3.0. Bst 2.0 failed to amplify at 72 °C,
whereas Bst 3.0 continued amplifying until 76 °C. At short
ampliﬁcation times, (such as 10 min), Bst 3.0 had greater
ampliﬁcation eﬃciency than Bst 2.0 (42.8% vs 20.8%,
respectively). In contrast, at longer ampliﬁcation times, such
at 30 or 45 min, eﬃciency for the enzymes was similar (77.6%
vs 71.5% at 45 min, respectively), although Bst 2.0 had slightly
greater ampliﬁcation eﬃciency than Bst 3.0.
We hypothesize that increased temperature improved
ampliﬁcation eﬃciency (presumably by increasing the breath-
ing of dsDNA and facilitating primer annealing) until, at higher
temperatures, a combination of enzyme denaturation or failure
of the primers to anneal occurred. Our primers had melting
temperatures ranging from 56−61 °C, when excluding the
secondary FIP and BIP annealing regions, as calculated using
OligoCalc.35 We found that chip-to-chip variability was
extremely low. Relative error for Bst 2.0 at optimal temperature
(68 °C) and 45 min of ampliﬁcation was ∼2% (Figure 2a),
whereas the predicted Poisson noise for a single chip is 0.7%.
Achieving such high precision using bulk measurements would
require hundreds of experiments. The low variability among
these measurements indicates that we were correctly
determining whether a partition contained solution and
whether it ampliﬁed.
Nonspeciﬁc Background Ampliﬁcation. Next, we
quantiﬁed the amount of nonspeciﬁc ampliﬁcation (Figure
3c,d) as a function of time and temperature. We plotted the
number of wells that turned “on” in the absence of template
relative to the total number of wells ﬁlled with LAMP solution.
As previously stated, these nonspeciﬁc ampliﬁcation reactions
included buﬀer in place of template and represented a best-
case scenario. We concluded that at least for these idealized
conditions, nonspeciﬁc ampliﬁcation in dLAMP was extremely
low. For example, a fraction of 0.001 could correspond to 20
partitions turning on from among a total of 20000 possible
partitions. For both enzymes, we found the maximum fraction
of nonspeciﬁc ampliﬁcation per total partitions was 0.0012 for
times 20 min or less. The highest fraction of nonspeciﬁc
ampliﬁcation observed was 0.017 at 45 min, corresponding to
fewer than 350 nonspeciﬁc partitions of the 20000 total
(Figure 3c,d). Furthermore, we observed that higher temper-
atures resulted in lower nonspeciﬁc ampliﬁcation (Figure
3c,d). Finally, at extremely long ampliﬁcation times (e.g., 60
min ampliﬁcation, data not shown), Bst 2.0 had lower
background than Bst 3.0.
Variations in Speed and Ampliﬁcation Eﬃciency.
Third, we quantiﬁed the variation in speed and ampliﬁcation
eﬃciency across partitions in the time to reach ﬂuorescence
intensity threshold (Figure 3e,f). We ﬁrst plotted the percent
copies detected as a function of time for each temperature. As
described previously, these curves represent the distribution in
the time to threshold across all partitions and thus illustrate the
interplay of (i) detecting a molecule (area under the curve
from zero to a given time corresponding to the values plotted
in Figure 3a,b), (ii) the speed of the reaction (the time at
which the peak reaches a maxima), and (iii) several parameters
of peak width summarized in Supporting Information, Table
S1. We hypothesize peak width is related to both the enzyme
ampliﬁcation rate, overall ampliﬁcation eﬃciency, and the time
at which the reaction initiates. Next, we plotted the peak time
to threshold (Supporting Information, Figure S1). Images were
collected in 30 s intervals, and we report the average of three
trials. In some cases, the diﬀerence in time to threshold was
less than the imaging time interval. For each time point, if
fewer than 15 partitions (0.075% of total partitions) were “on,”
that time point was not included in the calculation of the
mode. For these measurements, at the start of the reaction, the
heat block was at 25 °C and the time to threshold included the
time for the heat block to come to reaction temperature (∼70
s). Hence, there will be minor diﬀerences (seconds) in the
time for each reaction to reach the ﬁxed temperature. We do
not see evidence that this diﬀerence manifests in the mode
time to positive (TTP) measurements.
In reactions with Bst 2.0, below 68 °C, mode TTP was
narrowly clustered around 9.5 min. At 70 °C, mode TTP
increased and the reaction failed to amplify beyond 72 °C. In
reactions with Bst 3.0, the mode TTP decreased from 8.2 ± 0.3
(mode ± SD) min at 64 °C to 6.6 ± 0.3 min at 70 °C, then
increased with increasing temperature until ampliﬁcation failed
for all partitions at temperatures ≥76 °C. In the negative
controls for both enzymes (Supporting Information, Figure
S1), ampliﬁcation either failed or started after 75 min.
Several observations can be made by comparing the results
from Figure 3e,f. We found that the optimal temperature for
time to threshold corresponded with the optimal temperature
for ampliﬁcation eﬃciency (Figure 3a,b) and that the optimal
temperatures also had the smallest tailing factors, full width at
half-maximum (fwhm) and asymmetric factor (i.e., narrowest
peak widths) (Figure 3e,f; Supporting Information, Table S1).
At optimal eﬃciency, Bst 3.0 was approximately 2 min faster in
mode TTP, had much narrower fwhm, smaller tailing factor,
and lower asymmetry than Bst 2.0. Finally, as eﬃciency
decreased, measurements of peak shape and width increased.
To the best of our knowledge, this is the ﬁrst published
quantiﬁcation that explicitly tests and quantiﬁes the time
dependence of LAMP eﬃciency using these enzymes. Real-
time digital enables us to identify the time point at which the
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observed concentration most closely approximates the true
concentration thus optimizing the assay duration.
Rates of Ampliﬁcation (Speciﬁc and Nonspeciﬁc).
Fourth, we compared the rates of speciﬁc and nonspeciﬁc
ampliﬁcation between Bst 2.0 and Bst 3.0. The data shown
represent the combined rates of three separate trials. We found
that nonspeciﬁc ampliﬁcation rates were similar for the two
enzymes (Figure 3g, dashed lines), whereas in the presence of
template, ampliﬁcation rates were faster for Bst 2.0 than Bst 3.0
(Figure 3g, solid lines) despite lower eﬃciency at short times.
Diﬀerences in camera sensitivity between the microscope
(used for real-time images in Figure 2) and the RTAI (used for
Figure 3) result in diﬀerent apparent ampliﬁcation rates.
We also examined the relationship between temperature,
eﬃciency, and maximum rate. In the case of Bst 3.0, maximum
reaction ampliﬁcation rate does not correspond with optimal
eﬃciency (Figure 3h). A temperature of 64 °C had the fastest
ampliﬁcation rates but suboptimal eﬃciency (57.3% at 45
min). Optimal ampliﬁcation eﬃciency occurs at 68 °C (71.5%
at 45 min) but slightly slower ampliﬁcation rate than 64 °C. At
74 °C, we observed both poor eﬃciency (32.7% at 45 min)
and the slowest reaction rate. We attribute this to a
combination of decreased enzymatic velocity and decreased
primer annealing. Additionally, we note that diﬀerent thresh-
olds for ampliﬁcation rate would be needed for each
temperature. This is expected given changes in enzymatic
velocity.
Application of the Pipeline to a Phenotypic Anti-
biotic Susceptibility Test (AST) Using Clinical Samples.
We next asked whether we could apply the output of this
digital real-time pipeline to perform a rapid phenotypic AST.
Speciﬁcally, we aimed to categorically sort clinical samples as
phenotypically “susceptible” or “resistant” to an antibiotic in
agreement with the gold-standard reference method. This
study was constructed as a demonstration of the capability of
the microﬂuidic chips and the value gained from using this
digital real-time pipeline to optimize reaction conditions; it was
not an assessment of the digital AST (dAST) methodology
established previously.17,18 We selected the optimal dLAMP
conditions for Bst 3.0 based on the measurements of mode
TTP and ampliﬁcation eﬃciency established in the previous
experiments (Figure 3b), 70 °C and a reaction time of 10 min.
We used archived clinical urine samples from patients
diagnosed with urinary tract infections (UTI) containing E.
coli. These samples had been categorized as phenotypically
susceptible or resistant to the antibiotics ciproﬂoxacin or
nitrofurantoin using the gold-standard (broth microdilution)
method.18 We tested exactly 17 samples and observed 100%
categorical agreement with the gold-standard method (0 major
errors; 0 minor errors). We conclude that the pipeline
presented in this paper performs well and could be used,
among other applications, to optimize reaction conditions for
speed and sensitivity and apply those conditions to a
determination of phenotypic antibiotic susceptibility in clinical
samples.
■ CONCLUSION
We have presented a pipeline to generate real-time, digital
isothermal ampliﬁcation measurements using only commercial
and open-source components. We used this pipeline to
examine how small changes in reaction conditions inﬂuence
the interplay of LAMP eﬃciency, speed, and background by
performing 124 real-time dLAMP experiments. As one
practical application of this approach, we determined the
optimal reaction conditions for a phenotypic test of antibiotic
susceptibility using 17 clinical urine samples from patients
diagnosed with urinary tract infections. In all cases, the results
of the optimized dLAMP assays were in agreement with the
clinical gold-standard AST.
These experiments validate that real-time digital measure-
ments enable tests of enzymatic performance in dLAMP.
Generally, we found that each enzyme had a unique optimal
temperature for ampliﬁcation eﬃciency (probability of
detecting a target molecule) and for eliminating nonspeciﬁc
ampliﬁcation. This “optimal” temperature produced the fastest
mode TTP and the narrowest, most symmetrical distribution
curves; interestingly, the optimal temperature did not
necessarily yield the fastest ampliﬁcation rate. Together,
these data suggest that ampliﬁcation eﬃciency is an interplay
of enzymatic rate, diﬀusive transport, and DNA breathing.
When reactions are performed away from optimal temperature,
the distribution curves broaden and decrease in total area,
resulting in reduced overall ampliﬁcation eﬃciency and slower
mode TTP, whereas ampliﬁcation rate decreases with
increasing temperature. With regard to the speciﬁc enzymes
in this study, although eﬃciency was similar at long
ampliﬁcation times (>20 min), Bst 3.0 had a faster mode
TTP than Bst 2.0 by approximately 2 min and more narrow
and symmetrical distribution curves. However, Bst 2.0 had
faster ampliﬁcation rates than Bst 3.0, so reactions with Bst 2.0
took longer to initiate but proceeded more rapidly. For both
polymerases, nonspeciﬁc ampliﬁcation in buﬀer was extremely
low.
In the future, this pipeline can be used to understand the
fundamental pieces of LAMP. The ﬁeld of diagnostics would
beneﬁt from a thorough mechanistic study of LAMP by asking
which components determine ampliﬁcation fate and how
components, such as primers and heating rate (Supporting
Information, Figure S2), impact reaction and enzymatic speed.
Figure 4. Phenotypic antibiotic susceptibility tests of 17 clinical urine
samples from patients infected with a urinary tract infection
containing E. coli. Susceptibility to the antibiotics nitrofurantoin and
ciproﬂoxacin were tested using dLAMP conditions optimized using
digital real-time experiments (Figure 3). Urine samples were exposed
to media without antibiotic (control) or media with an antibiotic
(treated) for 15 min, and then concentrations of nucleic acids were
quantiﬁed to calculate a control:treated (C:T) ratio. Samples were
categorized by dLAMP as susceptible (above the susceptibility
threshold) or resistant (below the threshold). All samples were
categorized in agreement with the clinical gold-standard method.
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This pipeline makes such a mechanistic study possible. For
example, in this study, we corrected the observed concen-
tration by separating true positives from background
ampliﬁcation using rate and ﬂuorescence, but we did not
explore the origins of nonspeciﬁc amplicons, which deserves its
own study and development of more precise tools for studies
of nonspeciﬁc ampliﬁcation. Finally, this pipeline can be
extended to optimize other isothermal ampliﬁcation chem-
istries that could be suited to other types of diagnostic assays.
Ultimately, this pipeline will make digital real-time measure-
ments more accessible to researchers, even those who lack
microﬂuidic expertise or specialized equipment. The commer-
cially available chips and reagents used here could be coupled
with many combinations of standard laboratory or ﬁeld
equipment such as a hot plate and a ﬂuorescent stereoscope
or a chemical heater and a cell phone camera. Although we
believe the general trends found in this paper will extend to
other primer sets, we hope this pipeline will enable others to
study other primer sets and conditions of interest to them.
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